Cargando…
Fascin-1 is a novel biomarker of aggressiveness in some carcinomas
Tremendous progress has been made in recent years towards the understanding, prevention and management of malignant disease, yet cancer remains a leading cause of global mortality and morbidity. Current approaches towards combating this disease include prevention, early detection and various treatme...
Autores principales: | Kulasingam, Vathany, Diamandis, Eleftherios P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626678/ https://www.ncbi.nlm.nih.gov/pubmed/23443037 http://dx.doi.org/10.1186/1741-7015-11-53 |
Ejemplares similares
-
Genomic profiling for copy number changes in plasma of ovarian cancer patients – a new era for cancer diagnostics?
por: Kulasingam, Vathany, et al.
Publicado: (2016) -
Towards personalized tumor markers
por: Kulasingam, Vathany, et al.
Publicado: (2017) -
Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification
por: Ren, Annie H., et al.
Publicado: (2021) -
Unraveling endometriosis-associated ovarian carcinomas using integrative proteomics
por: Leung, Felix, et al.
Publicado: (2018) -
Deciphering the ovarian cancer ascites fluid peptidome
por: Bery, Anand, et al.
Publicado: (2014)